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Abstract 
N-Acetyltransferase  2  (NAT2)  genotyping  may  result  in  a  considerable 
percentage  in  several  ambiguous  allele  combinations.  PHASE  2.1  is  a 
statistical  program  which  is  designed  to  estimate  the  probability  of  different 
allele  combinations.  We  have  investigated  haplotypes  of  2088  subjects 
genotyped for NAT2 according to standard PCR/RFLP methods. In 856 out of 
2088 cases the genotype was clearly defined by PCR/RFLP only. In many of 
the  remaining  cases  the  program  clearly  defined  the  most  probable  allele 
combination: In the case of *5A/*6C, *5B/*6A the probability for *5B/*6A is 99% 
whereas the alternative allele combination *5A/*6C can be neglected. Other 
combinations  cannot  be  allocated  with  a  comparable  high  probability.  For 
example  the  allele  combination  *5A/*5C,  *5B/*5D  provides  for  *5A/*5C  a 
probability of 69% whereas the estimation for *5B/*5D allele is only 31%. In the 
two  most  often  observed  constellations  in  our  data  [(*12A/*5B,  *12C/*5C); 
(*12A/*6A,  *12B/*6B,  *4/*6C)]  the  probability  of  allele  combination  was 
ascertained as follows: *12A/*5B, 98%; *12C/*5C, 1.4% and *12A/*6A, 82%; 
*4/*6C, 17%; *12B/*6B, 0%. The estimation of the NAT2 haplotype is important 
because the assignment of the NAT2 alleles *12A, *12B or *13 as a rapid or 
slow genotype has been discussed controversially. Otherwise the classification 
of alleles in subjects which are not showing a clearly allocation can result in a 
rapid or slow acetylation state. This assignment has an important role in survey 
of bladder cancer cases in the scope of occupational exposure with aromatic 
amines. 
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Introduction  
Haplotype  analysis  has  been  used  for  more  precise  localisation  of  genes 
investigating different processes in different populations (Xu et al. 2002). It may 
be also used for suggesting the most probable allele combination in cases in 
which  data  do  not  suggest  a  single  allele  combination.  For  example,  N-
acetyltransferase 2 (NAT2) genotyping may result in a considerable percentage 
in ambiguous allele combinations.  
 
One approach to overcome the problems of different possible allele combination 
is to combine genotyping and phenotyping. In a considerable number of cases 
the  result  of  genotyping  can  be  made  more  robust.  Nevertheless,  additional 
phenotyping  is  expensive,  time  consuming  and  in  a  number  of  cases  not 
feasible due to practical problems.  
 
Another approach to get more robust allele combinations is to apply a haplotype 
reconstruction  algorithm  which  aims  to  determine  the  most  likely  allele 
combination by using the haplotype of a gene. The haplotype is defined as the 
group of single nuclear polymorphisms (SNPs) which define a genotype e.g. of 
a polymorphic enzyme. Several computer programs which aim to determine the 
most probable allele combination of a gene are available (e.g., Grinberg and 
Mano 2004; Sobel et al. 1995; Wang and Xu 2003; Vijayasatya and Mukherjee 
2005; for review see Salem et al. 2005).  
 
In this study, the program PHASE 2.1, designed by Stephens and co-workers 
(Stephens  et  al.  2001;  Stephens  and  Donnelly  2003)  was  applied.  This 
program, written in DOS and thus asking for data input in the DOS level, uses a 
Baysian  approach  for  the  reconstruction  of  SNPs.  In  this  study,  SNPs  were 
derived  indirectly  from  genotyping  using  RFLP  and  PCR.  Calculation  is 
performed  by  Markov-Chain  Monte  Carlo  algorithms.  The  program  requires 
information on the relative distance of the investigated gene loci (in base pair 
units). The loci should be located on one chromosome. More than two alleles 
per  gene  locus  as  well  as  missing  values  are  allowed.  Use  of  background 
information  on  the  recombination  rate  is  possible.  We  have  investigated   4 
haplotypes of 2088 subjects genotyped for NAT2 according to standard PCR 
and RFLP based methods. 
 
 
Subjects and Methods  
A total of 2088 subjects who had visited the Central Unit Clinical Occupational 
Medicine in our institute for different purposes or who were members of study 
cohorts  in  different  hospitals,  mostly,  cases  of  urological  cancer,  colorectal 
cancer or controls were investigated. Each subject donated 10 ml EDTA blood. 
DNA  was  extracted  using  standard  methods.  Genotyping  for  NAT2  was 
performed using PCR and RFLP based standard methods (Bolt et al. 2005). A 
total  of  7  single  nucleotide  polymorphisms  (SNPs)  which  are  adequate  to 
genotype Caucasians for NAT2 were investigated (Figure 1).  
 
 
Fig.  1:  Seven  single  nucleotide  polymorphisms  (SNPs)  of  the  human  NAT2 
exon relevant in Caucasians. 
 
Haplotype analysis was performed using the program PHASE 2.1, developed 
by  Stephens  and  co-workers  (Stephens  et  al.  2001;  Stephens  and  Donnelly 
2003) and provided via world wide web  
(http://www.stat.washington.edu/stephens/).  After  registration,  the  licence  can 
be required for free for non-profit use. This program is running on the DOS level 
only.  Thus  data  presented  by  spreadsheet  programs  like  Excel  must  be 
presented using the DOS editor.  
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Statistical analysis 
The  estimation  of  individual  haplotype  pairs,  their  probability  as  well  as  the 
sample  haplotype  frequencies  was  performed  using  the  software  PHASE, 
version  2.1.  The  approach  underlying  PHASE  is  a  Bayesian  haplotype 
reconstruction method (see Stephens et al. 2001, Stephens and Donnelly 2003, 
for details).  
 
Suppose  we  have  a  sample  of  n  diploid  individuals  from  a  population.  Let 
G = (G1, …, Gn)  be  the  observed  genotypes  and  H = (H1, …, Hn)  denote  the 
unknown corresponding haplotype pairs. Let F = (F1, …, FM) denote the set of 
unknown  population  haplotype  frequencies  and  f = (f1, …, fM)  be  the  set  of 
unknown sample haplotype frequencies where 1, …, M is an arbitrary labelling 
of the M possible haplotypes. Considering the unknown haplotypes as random 
quantities  the  prior  information,  i.e.  the  assumptions  on  genetic  and 
demographic  models,  on  the  population  haplotype  frequency  F  etc,  and  the 
likelihood, i.e. the information given by the observed data leading, for instance, 
to estimates of the sample haplotype frequencies f, are combined to calculate 
the  posterior  distribution  Pr(H|G)  of  the  unobserved  haplotypes  H  given  the 
observed genotypes G. This is done by the use of Gibbs sampling, a Markov-
Chain Monte Carlo algorithm (Gilks et al. 1996).  
 
Hence,  the  individual  haplotypes  can  be  estimated  from  this  posterior 
distribution by choosing, for instance, the most likely haplotype reconstruction 




In 856 out of 2088 cases the genotype was clearly defined by PCR and RFLP 
based standard methods only. A re-analyses of the clearly defined 856 cases 
confirmed the results. Only in 19 of these cases an additional genotype was 
offered (Table 1, 2). 
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Table 1: Rate and absolute number of allele combinations of NAT2 in 2088 
subjects. 
Alleles  Rate (%)  Number (n)  Assigned Phenotype 
*4/*4  4.74  99  rapid 
*4/*5A  1.34  28  intermediary 
*4/*6B  0.04  1  intermediary 
*4/*7A  0.04  1  intermediary 
*4/*7B  0.04  1  intermediary 
*5A/*5A  0.09  2  slow 
*5A/*5B  1.81  38  slow 
*5A/*5C  0.04  1  slow 
*5A/*5C, *5B/*5D  0.19  4  slow 
*5A/*6A  1.62  34  slow 
*5A/*6B  0.09  2  slow 
*5A/*6C , *5B/*6A  24.23  506  slow 
*5A/*7B  0.19  4  slow 
*5B/*5B  16.52  345  slow 
*5B/*5C  1.48  31  slow 
*5B/*6B  0.23  5  slow 
*5B/*6C  0.04  1  slow 
*5B/*7A  0.09  2  slow 
*5B/*7B  2.05  43  slow 
*5C/*6A  0.14  3  slow 
*5C7*7B  0.04  1  slow 
*6A7*6A  7.80  163  slow 
*6A/*6B  0.14  3  slow 
*6A/*7B  0.95  20  slow  
*6B/*13 , *4/*6A  2.20  46  intermediary-rapid 
*6B/*6B  0.04  1  slow 
*12A/*4  0.14  3  rapid 
*12A/*5A , *12C/*5D , *4/*5B  17.24  360  slow-rapid 
*12A/*5B , *12C/*5C  0.43  9  intermediary? 
*12A/*5C  0.04  1  intermediary? 
*12A/*5D , *4/*5C  0.76  16  slow-rapid 
*12A/*6A , *12B/*6B , *4/*6C  0.23  5  intermediary 
*12A/*6B  0.04  1  intermediary? 
*12A/*7B , *12B/*7A  0.04  1  intermediary? 
*12B/*5A , *13/*5B  0.19  4  intermediary 
*12B/*5E , *5C/*6A , *5D/*6C  0.71  15  slow  
*12B/*6A  0.09  2  intermediary 
*12C/*4  0.04  1  rapid 
*12C/*12C  0.04  1  rapid 
*12C/*13  0.04  1  rapid 
*12C/*5A  0.28  6  preliminary 
*13/*4  0.14  3  rapid 
*13/*13  0.04  1  rapid 
*13/*6B , *4/*6A  11.78  246  slow-rapid 
*13/*7A , *4,*7B  1.14  24  slow-rapid 
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Table 2: Frequencies of allele combinations of the NAT2 genotype in 2088 
subjects clearly defined by PCR and RFLP based standard methods only. 
Frequency  Allele combination  Number (n) 
   
*5A/*5B  17  17 x 100 %   
*5A/*6A  34  26 x 100 %,  8 x 99% 
*5B/*5B  345  344 x 100%  1 x not identified 
*5B/*5C  31  31 x 100%   
*5B/*7B  43  43 x 100%   
*6A/*6A  163  162 x 100%  1 x not identified 
*6A/*7B  20  20 x 100%   
 
In  many  of  the  remaining  cases  with  two  or  three  possible  alternative  allele 
combinations the program clearly defined the most probable allele combination: 
In  the  case  of  *5A/*6C,  *5B/*6A  the  probability  for  *5B/*6A  is  99%  and  the 
alternative allele combination *5A/*6C may be neglected (Table 1, 3). 
 
Table 3: Frequencies of alternative allele combinations of the NAT2 genotype in 
2088 subjects. 
Allele combinations  Number (n)  Frequency of combinations 
*4/*5A  28  28 x *4/*5A,100 % 
*5A/*6C , *5B/*6A  506  506 x *5A/*6C, 99 % 
*12A/*5A , *12C/*5D , *4/*5B  360  360 x *4/*5B, 99 % 
*12A/*5D , *4/*5C  16  16 x *4/*5B, 99 % 
*12A/*6A , *12B/*6B , *4/*6C  3  3 x  *4/*6C, 17.2%; *12° /*6A, 82 % 
*12B/*5E , *5C/*6A , *5D/*6C  15  15 x *5C/*6A, 99% 
*13/*6B , *4/*6A  247  247 x *4/*6A 
*13/*7A , *4/*7B  24  24 x *4/*7B, 99% 
 
Other combinations cannot be allocated with a comparable high probability. For 
example  the  allele  combination  *5A/*5C,  *5B/*5D  provides  for  *5A/*5C  a 
probability of 69% whereas the estimation for *5B/*5D allele is only 31%. In the 
two  most  often  observed  constellations  in  our  data  [(*12A/*5B,  *12C/*5C); 
(*12A/*6A,  *12B/*6B,  *4/*6C)]  the  probability  of  allele  combination  was  as 
follows:  *12A/*5B,  98%;  *12C/*5C,  1.4%  and  *12A/*6A,  82%;  *4/*6C,  17%; 
*12B/*6B, 0% (Table 1, 4).  
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Table 4: Present assignment of human NAT2 alleles (Butcher et al. 2002; 
Arylamine N-Acetyltransferase Nomenclature Committee 2003). 
Present assignment of human NAT2 alleles 
Allele  Phenotype  Nucleotide change(s) 
NAT2*4  Rapid  none 
NAT2*5A  Slow  341T>C, 481C>T 
NAT2*5B  Slow  341T>C, 481C>T, 803A>G 
NAT2*5C  Slow  341T>C, 803A>G 
NAT2*5D  Slow  341T>C 
NAT2*5E  Slow  341T>C, 590G>A 
NAT2*5F  Slow  341T>C, 481C>T, 759C>T, 803A>G 
NAT2*6A  Slow  282C>T, 590G>A 
NAT2*6B  Slow  590G>A 
NAT2*6C  Slow  282C>T, 590G>A, 803A>G 
NAT2*6D  Slow  111T>C, 282C>T, 590G>A 
NAT2*7A  Slow  857G>A 
NAT2*7B  Slow  282C>T, 857G>A 
NAT2*10  Unknown  499G>A 
NAT2*11  Unknown  481C>T 
NAT2*12A  Rapid  803A>G 
NAT2*12B  Rapid  282C>T, 803A>G 
NAT2*12C  Rapid  481C>T, 803A>G 
NAT2*13  Rapid  282C>T 
NAT2*14A  Slow  191G>A 
NAT2*14B  Slow  191G>A, 282C>T 
NAT2*14C  Slow  191G>A, 341T>C, 481C>T, 803A>G 
NAT2*14D  Slow  191G>A, 282C>T, 590G>A 
NAT2*14E  Slow  191G>A, 803A>G 
NAT2*14F  Slow  191G>A, 341T>C, 803A>G 
NAT2*14G  Slow  191G>A, 282C>T, 803A>G 
NAT2*17  Slow  434A>C 
NAT2*18  Unknown  845A>C 
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Discussion and Conclusions  
The estimation of the NAT2 haplotype is important because the assignment of 
the  NAT2  alleles  *12A,  *12B  or  *13  as  a  rapid  or  slow  genotype  is  being 
discussed controversially (see Bolt et al. 2005). The classification of alleles in 
subjects not showing a clear allocation can result in a rapid or slow acetylation 
state (see figure 2 for illustration). This assignment has an important role in 
surveys  of  bladder  cancer  cases  elicited  by  occupational  exposures  with 
aromatic amines. However, molecular haplotyping methods are labour-intensive 
and expensive. Thus, the use of haplotype reconstruction algorithms such as 
PHASE provides an effective alternative yielding good results (Sabbagh and 




Fig. 2: Individual NAT2 phenotyping data (ratios of urinary AFMU/1X), 
allocated to genotypic groups of ambiguous NAT2 alleles (extracted 
from Bolt et al. 2005) 
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A mayor drawback of this program is that it is running on the DOS level only. 
Thus data presented by spreadsheet programs like Excel must be presented 
using the DOS editor, which is a problem at least for all those not familiar with 
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